Pi™ matches the accuracy of expert radiologists

The results of a major collaborative research study with 8 UK NHS hospitals, PAIR-1, have been published in the leading journal European Radiology. This study is a landmark in the development and validation of AI for prostate cancer, showing for the first time that Pi™ operates at the level of expert radiologists working in multi-disciplinary teams, across real-world, multi-centre data encompassing different MRI scanner vendors, models and field strengths.This found that Pi™ has outstanding accuracy to detect clinically significant prostate cancer on representative, held-out validation data, with 95% sensitivity and 67% specificity. This high performance allows Pi™ to be used to help find more cancers, rule out patients who do not need further investigations, and save resources and time

Full paper in European Radiology